Preoperative Local Administration of Morphine as an Add-on Therapy in Patients Undergoing Surgical Removal of an Odontogenic Maxillary Cyst. A Randomized, Double-Blind Pilot Study

Aims: To evaluate whether a combination of locally administered morphine (1 mg) and lidocaine as part of a multimodal analgesic approach is safe, and whether it improves pain control during the first 24 hours after odontogenic maxillary cyst removal under general anesthesia compared to local lidocaine alone. Methods: In a double-blind, sham-controlled, single-center trial, patients scheduled for surgical removal of an odontogenic maxillary cyst under general anesthesia were randomly assigned to receive a local injection of lidocaine solution with either 1 mg of morphine (MLA group) or with no morphine (LA group). Pain management included intravenous acetaminophen (1 g every 6 hours) in all patients. Upon request, the patients could additionally receive ketoprofen (first-line additional analgesia) or tramadol (second-line additional analgesia). Pain intensity was assessed using a numeric rating scale. Primary outcome measures were (1) no need for any additional analgesic therapy and (2) time to the first rescue analgesic therapy during the first 24 hours after the surgery. Results: Of 48 eligible patients, 24 were allocated to the MLA group and 24 to the LA group. The necessity of additional ketoprofen therapy did not differ significantly between the groups (25.0% vs 50.0%, P = .074). According to the Kaplan-Meier analysis, the probability of remaining without additional analgesic intervention was significantly higher in the MLA group (log-rank test, P = .040), but there were no significant (P > .05) differences in overall and maximum pain severity between the two groups. No adverse effects of morphine were recorded. Conclusion: Within the limitations of this study, local administration of 1 mg of morphine prior to the surgical removal of an odontogenic maxillary cyst was safe, but it did not prove to be very effective as an add-on therapy for postoperative pain control.

inflammatory pain; odontogenic cysts; opioid receptors; oral surgery; peripheral opioid analgesia

1. Curatolo M, Sveticic G. Drug combinations in pain treatment: A review of the published evidence and a method for finding the optimal combination. Best Pract Res Clin Anaesthesiol 2002; 16:507–519.

2. Picard PR, Tramer MR, McQuay HJ, Moore RA. Analgesic efficacy of peripheral opioids (all except intra-articular): A qualitative systemic review of randomised controlled trials. Pain 1997; 72:309–318.

3. Kaczmarzyk T, Stypulkowska J. Assessment of the effectiveness of peripheral administration of morphine with local articaine anaesthesia for surgery in inflamed oral and maxillofacial tissues. Pain 2005;115:348–354.

4. Likar R, Koppert W, Blatnig H, et al. Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J Pain Symptom Manage 2001;21:330–337.

5. Ji RR, Zhang Q, Law PY, Low HH, Elde R, Hökfelt T. Expression of mu-, delta-, and kappaopioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 1995;15:8156–8166.

6. Zöllner C, Shaqura MA, Bopaiah CP, Mousa SA, Stein C, Schäfer M. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 2003;64:202–210.

7. Nu˜néz S, Lee JS, Zhang Y, Bai G, Ro JY. Role of peripheral mu-opioid receptors in inflammatory orofacial muscle pain. Neuroscience 2007;146:1346–1354.

8. Likar R, Sittl R, Gragger K, et al. Peripheral morphine analgesia in dental surgery. Pain 1998;76:145–150.

9. Furst IM, Kryshtalskyj B, Weinberg S. The use of intra-articular opioids and bupivacaine for analgesia following temporo-mandibular joint arthroscopy: A prospective, randomized trial. J Oral Maxillofac Surg 2001;59:979–983.

10. Varinauskas V, Gervickas A, Kavoliu˜niene O. Analysis of odontogenic cysts of the jaws. Medicina (Kaunas) 2006;42: 201–207.

11. Muglali M, Komerik N, Bulut E, Yarim GF, Celebi N, Sumer M. Cytokine and chemokine levels in radicular and residual cyst fluids. J Oral Pathol Med 2008;37:185–189.

12. Meghij S, Qureshi W, Henderson B, Harris M. The role of endotoxin and cytokines in the pathologenesis of odontogenic cysts. Arch Oral Biol 1996;41:523–531.

13. Członkowski A, Stein C, Herz A. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cyto-kines. Eur J Pharmacol 1993;242:229–235.

14. Dripps RD. New classification of physical status [editorial]. Anesthesiology 1963;24–111.

15. Frane JW. A method of biased coin randomization, its implementation and its validation. Drug Inf J 1998;32:423–432.

16. Weil LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials 1988;9:345–364.

17. Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg 1970;49:924–934.

18. Shannon HE, Lutz EA. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology 2002;42: 253–261.

19. Labuz D, Mousa SA, Schafer M, Stein C, Machelska H. Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res 2007;1160:30–38.

20. Machelska H, Schopohl JK, Mousa SA, Labuz D, Schafer M, Stein C. Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol 2003;141:30–39.

21. Likar R, Kapral S, Steinkellner H, Stein C, Schäfer M. Dose-dependency of intra-articular morphine analgesia. Br J Anaesth 1999;83:241–244.

22. Richardson MD, Bjorksten AR, Hart JA, McCullough K. The efficacy of intra-articular morphine for postoperative knee arthroscopy analgesia. Arthroscopy 1997;13:584–589.

23. Kalso E, Tramer MR, Carroll D, McQuay HJ, Moore RA. Pain relief from intra-articular morphine after knee surgery: A qualitative systemic review. Pain 1997;71:127–134.

24. Bakke M, Hu JW, Sessle BJ. Morphine application to peripheral tissues modulates nociceptive jaw reflex. Neuroreport 1998;9:3315–3319.

25. Sanchez EM, Bagues A, Martin MI. Contributions of peripheral and central opioid receptors to antinociception in rat muscle pain models. Pharmacol Biochem Behav 2010;96:488–495.

26. Dionne RA, Lepinski AM, Gordon SM, Jaber L, Brahim JS, Hargreavest KM. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther 2001;70:66–73.

27. Moore UJ, Seymour RA, Gilroy J, Rawlins MD. The efficacy of locally applied morphine in post-operative pain after bilateral third molar surgery. Br J Clin Pharmacol 1994;37:227–230.

28. Arici S, Gurbet A, Türker G, Yavas¸caog˘lu B, Sahin S. Preemptive analgesic effects of intravenous paracetamol in total abdominal hysterectomy. Agri 2009;21:54–61.

29. Dobrogowski J, Mayzner-Zawadzka E, Drobnik L, Kusza K, Woron´ J, Wordliczek J. Postoperative pain management—recommendation 2008. Ból 2008;9:9–22.

30. Sloman R, Wruble AW, Rosen G, Rom M. Determination of clinically meaningful levels of pain reduction in patients experiencing acute postoperative pain. Pain Manag Nurs 2006;7:153–158.

31. Moskovitz BL, Benson CJ, Patel AA, Chow W, Mody SH, McCarberg BH. Analgesic treatment for moderate-to-severe acute pain in the United States: patients’ perspectives in the Physicians Partnering Against Pain (P3) survey. J Opioid Manag 2011;7:277–286.

32. Gordon DB, Dahl JL, Miaskowski C, et al. American pain society recommendations for improving the quality of cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 2005;165:1574–1580.

33. Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W. Determination of moderate-to-severe postoperative pain on the numeric rating scale: A cut-off point analysis applying four different methods. Br J Anaesth 2011;107:619–626.

34. van Dijk JF, Wijck AJ, Kappen TH, Peelen LM, Kalkman CJ, Schuurmans MJ. Postoperative pain assessment based on numeric ratings is not the same for patients and professionals: A cross-sectional study. Int J Nurs Stud 2012;49:65–71.

35. Cai BB, Cairns BE, Sessle BJ, Hu JW. Sex-related suppression of reflex jaw muscle activity by peripheral morphine but not GABA. Neuroreport 2001;16:3457–3460.

36. Zhang X, Zhang Y, Asgar J, Niu KY, Lee J, Lee KS, et al. Sex differences in mu opioid receptor expression in trigeminal ganglia under a myositis condition in rats. Eur J Pain 2014;18:151–161.

37. Tighe PJ, Riley JL 3rd, Fillingim RB. Sex differences in the incidence of severe pain events following surgery: A review of 333,000 pain scores. Pain Med 2014;15:1390–1404.

38. de Santana-Santos T, de Souza-Santos JAS, Martins-Filho PRS, et al. Prediction of postoperative facial swelling, pain and trismus following third molar surgery based on preoperative variables. Med Oral Patol Oral Cir Bucal 2013;18:e65–e70.

39. Aoki Y, Yoshida K, Nishizawa D, et al. Factors that affect in-travenous patient-controlled analgesia for postoperative pain following orthognathic surgery for mandibular prognathism. PLoS One 2014;9:e98548.

40. Liu W, Cong R, Li X, Wu Y, Wu H. Reduced opioid consumption and improved early rehabilitation with local and intraarticular cocktail analgesic injection in total hip arthroplasty: A random-ized controlled clinical trial. Pain Med 2011;12:387–393.